Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.68
+1.20 (26.79%)
At close: May 12, 2025, 4:00 PM
5.59
-0.09 (-1.58%)
After-hours: May 12, 2025, 4:57 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $34.73 million as of May 12, 2025. Its market cap has decreased by -44.64% in one year.
Market Cap
34.73M
Enterprise Value
-102.59M
1-Year Change
-44.64%
Ranking
Category
Stock Price
$5.68
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $34.73M, a decrease of -93.72%. That is a compound annual growth rate of -45.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 27.39M | -81.48% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.30B |
| Johnson & Johnson | 372.70B |
| UnitedHealth Group | 343.89B |
| AbbVie | 338.11B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 230.98B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |